Updated Jul 16, 2026
LEVIN JEREMY M is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.

Jeremy M. Levin is a prominent biotechnology executive known for his leadership roles in various pharmaceutical and biotechnology companies. He has served as the CEO of Ovid Therapeutics Inc., where he focuses on developing innovative therapies for neurological disorders. Levin has a strong background in the life sciences and has held senior positions at several other companies, contributing to advancements in drug development and commercialization.
| Role | Insider |
|---|---|
| Notability | 75/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-26 | OVID | Ovid Therapeutics Inc. | M — Option exercise | 47.3K | $1.40 | $66K |
Jeremy M. Levin is a prominent biotechnology executive known for his leadership roles in various pharmaceutical and biotechnology companies. He has served as the CEO of Ovid Therapeutics Inc., where he focuses on developing innovative therapies for neurological disorders. Levin has a strong background in the life sciences and has held senior positions at several other companies…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live LEVIN JEREMY M profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.